MYCOVIA PHARMACEUTICALS INC FDA Approval NDA 215888

NDA 215888

MYCOVIA PHARMACEUTICALS INC

FDA Drug Application

Application #215888

Documents

Letter2022-04-27
Label2022-04-28
Review2022-05-11

Application Sponsors

NDA 215888MYCOVIA PHARMACEUTICALS INC

Marketing Status

Prescription001

Application Products

001CAPSULE; ORAL150MG0VIVJOAOTESECONAZOLE

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP2022-04-26PRIORITY

Submissions Property Types

ORIG1Null7

CDER Filings

MYCOVIA PHARMACEUTICALS INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 215888
            [companyName] => MYCOVIA PHARMACEUTICALS INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"VIVJOA","activeIngredients":"OTESECONAZOLE","strength":"150MG","dosageForm":"CAPSULE; ORAL","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"}]
            [labels] => [{"actionDate":"04\/26\/2022","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2022\\\/215888s000lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"04\/26\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 1 - New Molecular Entity","reviewPriority":"PRIORITY","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2022\\\/215888s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2022\\\/215888Orig1s000ltr.pdf\"}]","notes":">"}]
            [supplements] => 
            [actionDate] => 2022-04-26
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.